• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
TopoTarget A/S - Product Pipeline Review - Q1 2011 Product Image

TopoTarget A/S - Product Pipeline Review - Q1 2011

  • Published: March 2011
  • Region: Global
  • 53 pages
  • Global Markets Direct

TopoTarget A/S – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “TopoTarget A/S - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- TopoTarget A/S - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TopoTarget A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the READ MORE >



List of Tables
List of Figures
TopoTarget A/S Snapshot
TopoTarget A/S Overview
Key Information
Key Facts
TopoTarget A/S – Research and Development Overview
Key Therapeutic Areas
TopoTarget A/S – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
TopoTarget A/S – Pipeline Products Glance
TopoTarget A/S Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
TopoTarget A/S–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
TopoTarget A/S – Drug Profiles
APO866
Product Description
Mechanism of Action
R&D Progress
Avugane
Product Description
Mechanism of Action
R&D Progress
Belinostat
Product Description
Mechanism of Action
R&D Progress
Belinostat + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Belinostat + Carboplatin + Paclitaxel
Product Description
Mechanism of Action
R&D Progress
Belinostat + Paclitaxel
Product Description
Mechanism of Action
R&D Progress
Belinostat + Tarceva
Product Description
Mechanism of Action
R&D Progress
PXD101 + Doxorubicin
Product Description
Mechanism of Action
R&D Progress
PXD101 + Idarubicin
Product Description
Mechanism of Action
R&D Progress
APO010
Product Description
Mechanism of Action
R&D Progress
PXD101 + 5-FU
Product Description
Mechanism of Action
R&D Progress
Zemab
Product Description
Mechanism of Action
R&D Progress
HSP90 Inhibitors
Product Description
Mechanism of Action
R&D Progress
mTOR Inhibitors
Product Description
Mechanism of Action
R&D Progress
TOP216
Product Description
Mechanism of Action
R&D Progress
TopoTarget A/S – Pipeline Analysis
TopoTarget A/S – Pipeline Products by Therapeutic Class
TopoTarget A/S - Pipeline Products By Target
TopoTarget A/S – Pipeline Products by Route of Administration
TopoTarget A/S – Pipeline Products by Molecule Type
TopoTarget A/S – Recent Pipeline Updates
TopoTarget A/S - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
CHS 828
TopoTarget A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Dec 23, 2010: Spectrum's Phase II Combination Trial Of Belinostat Meets Enrollment Target
Dec 08, 2009: Positive Results Of TopoTarget’s Initial Phase II Study With Belinostat In PTCL And CTCL Presented At ASH
Dec 08, 2009: Positive Results Of TopoTarget’s Initial Phase II Study With Belinostat In PTCL And CTCL Presented At ASH
Mar 13, 2009: TopoTarget Reports Phase II Trial Results With Avugane In Acne Vulgaris
Dec 17, 2008: TopoTarget Initiates Recruitment Of Patients In Its Pivotal Trial Of Belinostat In Peripheral T-Cell Lymphoma (PTCL)
Dec 17, 2008: TopoTarget Initiates Recruitment Of Patients In Its Pivotal Trial Of Belinostat In Peripheral T-Cell Lymphoma (PTCL)
May 15, 2008: TopoTarget Announces Allowance Of Valproic Acid Patent In Europe covering Avugane
Dec 14, 2007: Infusion Nurses Society Referenced Totect(Dexrazoxane For Injection) as the Only Antidote for the Treating Anthracycline Extravasation.
Sep 07, 2007: Totect approved in the United States
Mar 12, 2007: TopoTarget Executes Its Licensing Option For The Development Of Zemab For Breast Cancer
Financial Deals Landscape
TopoTarget A/S, Deals Summary, 2004 to 2011
TopoTarget A/S Detailed Deal Summary
CuraGen And TopoTarget Enters Into Research Agreement With National Cancer Institute
Licensing Agreements
Spectrum Pharmaceuticals Enters Into Licensing Agreement With TopoTarget
CuraGen Enters Into Licensing Agreement With TopoTarget
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
TopoTarget A/S – Pipeline by Therapy Area and Indication, 2011
TopoTarget A/S – Pipeline by Stage of Development, 2011
TopoTarget A/S – Monotherapy Products in Pipeline, 2011
TopoTarget A/S – Combination Treatment Modalities in Pipeline, 2011
TopoTarget A/S - Phase II, 2011
TopoTarget A/S - Phase I, 2011
TopoTarget A/S - Pipeline By Therapeutic Class, 2011
TopoTarget A/S - Pipeline By Target, 2011
TopoTarget A/S – Pipeline By Route of Administration, 2011
TopoTarget A/S – Pipeline By Molecule Type, 2011
TopoTarget A/S – Recent Pipeline Updates, 2011
TopoTarget A/S - Discontinued Pipeline Products, 2010
TopoTarget A/S, Subsidiaries
TopoTarget A/S, Deals Summary, 2004 to 2011

List of Figures
TopoTarget A/S – Pipeline by Therapy Area and Indication, 2011
TopoTarget A/S – Pipeline by Stage of Development, 2011
TopoTarget A/S – Monotherapy Products in Pipeline, 2011
TopoTarget A/S – Combination Treatment Modalities in Pipeline, 2011
TopoTarget A/S – Pipeline By Therapeutic Class, 2011
TopoTarget A/S - Pipeline By Target, 2011
TopoTarget A/S – Pipeline By Route of Administration, 2011
TopoTarget A/S – Pipeline By Molecule Type, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS